IRINA RYBALOVA: Open Payments
NPI 1386864486 · NYACK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,456 in 159 payments from 41 companies in 2025. Trend: 2023 $3,220 · 2024 $2,831 · 2025 $4,456
Food & beverage: $3,000Long term medical supply or device loan: $1,180Education: $276
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 40 | $1,654 |
| SHIELD THERAPEUTICS INC | 13 | $273 |
| AstraZeneca Pharmaceuticals LP | 6 | $262 |
| Ipsen Biopharmaceuticals, Inc | 12 | $260 |
| PFIZER INC. | 11 | $183 |
| GlaxoSmithKline, LLC. | 6 | $147 |
| Janssen Biotech, Inc. | 3 | $141 |
| ABBVIE INC. | 9 | $141 |
| BeOne Medicines USA, Inc. | 6 | $117 |
| Daiichi Sankyo Inc. | 4 | $84 |
Products named: KISQALI, ACCRUFER, Fabhalta, Onivyde, ERLEADA, DATROWAY, ENHERTU, EPKINLY.
Industry payments across NY — which companies pay providers there.
